IMA
Price
$3.83Alerts
Change
+$0.02 (+0.52%)
Updated
Nov 11 closing price
Capitalization
47M
117 days until earnings call
Intraday BUY SELL Signals
RAPP
Price
$27.02Alerts
Change
+$1.06 (+4.08%)
Updated
Nov 11 closing price
Capitalization
1.17B
Intraday BUY SELL Signals
Interact to see
Advertisement

IMA vs RAPP

IMA vs RAPP Comparison Chart in %
View a ticker or compare two or three
VS
IMA vs. RAPP commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Hold and RAPP is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IMA with price predictions
Nov 11, 2026

IMA in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 10, 2026

IMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 42 cases where IMA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMA's RSI Oscillator exited the oversold zone, 28 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for IMA just turned positive on October 23, 2026. Looking at past instances where IMA's MACD turned positive, the stock continued to rise in 42 of 50 cases over the following month. The odds of a continued upward trend are 84%.

Following a +4.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMA advanced for three days, in 172 of 217 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMA as a result. In 91 of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for IMA entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.331) is normal, around the industry mean (3.498). P/E Ratio (-0.876) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (35.971) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. IMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for RAPP with price predictions
Nov 11, 2026

Momentum Indicator for RAPP turns positive, indicating new upward trend

RAPP saw its Momentum Indicator move above the 0 level on November 11, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator turned positive. In 43 of the 47 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RAPP's RSI Oscillator exited the oversold zone, 5 of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for RAPP just turned positive on October 19, 2026. Looking at past instances where RAPP's MACD turned positive, the stock continued to rise in 27 of 29 cases over the following month. The odds of a continued upward trend are 90%.

Following a +9.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where RAPP advanced for three days, in 124 of 140 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

RAPP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RAPP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for RAPP entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.773) is normal, around the industry mean (3.498). P/E Ratio (-8.066) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (92.593) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. RAPP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RAPP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
IMARAPP
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 17 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (IMA: $3.83 vs. RAPP: $27.02)
Brand notoriety: IMA and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 36% vs. RAPP: 69%
Market capitalization -- IMA: $47M vs. RAPP: $1.17B
IMA [@Biotechnology] is valued at $47M. RAPP’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green while RAPP’s FA Score has 2 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • RAPP’s FA Score: 2 green, 3 red.
According to our system of comparison, RAPP is a better buy in the long-term than IMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 5 TA indicator(s) are bullish while RAPP’s TA Score has 5 bullish TA indicator(s).

  • IMA’s TA Score: 5 bullish, 3 bearish.
  • RAPP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both IMA and RAPP are a good buy in the short-term.

Price Growth

IMA (@Biotechnology) experienced а -6.59% price change this week, while RAPP (@Biotechnology) price change was +4.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

IMA is expected to report earnings on Mar 09, 2027.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
+0.52%
CELC - IMA
77%
Closely correlated
-4.07%
SLXN - IMA
62%
Loosely correlated
+22.35%
SYRE - IMA
33%
Loosely correlated
+2.24%
RAPP - IMA
31%
Poorly correlated
+4.08%
RVMD - IMA
30%
Poorly correlated
-6.40%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with BCAX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then BCAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+4.08%
BCAX - RAPP
53%
Loosely correlated
+3.44%
STOK - RAPP
44%
Loosely correlated
+2.02%
LXEO - RAPP
43%
Loosely correlated
+0.33%
CLDX - RAPP
42%
Loosely correlated
-1.63%
BNTC - RAPP
42%
Loosely correlated
+2.05%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMOM29.240.46
+1.58%
Symmetry Panoramic Sector Momentum ETF (SMOM)
DBA26.360.10
+0.38%
Invesco DB Agriculture Fund (DBA)
APMU24.750.03
+0.11%
ActivePassive Intermediate Municipal Bond ETF (APMU)
GJS23.01-0.11
-0.48%
Synthetic Fixed-Income Securities STRATS 2006-2 Goldman Sachs Group
QTUP11.33-0.26
-2.24%
Defiance Long Pure Quantum ETF (QTUP)